Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score.

Saved in:

Bibliographic Details
Title:	Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score.
Authors:	Taha, Heba F.¹, Elsayed, Dalia Hamouda¹, Salem, Reham², Mandour, Doaa², Bayomy, Mohammed², Rashed, Hayam³, Kamel, Mostafa⁴, Elderey, Mohamed⁴, Elfarargy, Ola M.¹ elfarargyola@yahoo.com
Source:	Contemporary Oncology / Współczesna Onkologia. 2022, Vol. 26 Issue 3, p196-203. 8p.
Database:	Academic Search Ultimate

Description
ISSN:	14282526
DOI:	10.5114/wo.2022.120592